Haishan Li

Haishan Li is a Director Of R&D with experience in gamma/delta T cell/TCR-based immunotherapy for cancer and infectious diseases. Previously a Principal Scientist at American Gene Technologies International Inc., focusing on HIV immunotherapy. Also, held positions at the University of Maryland School of Medicine and Chinese Center for Disease Control and Prevention, where research on HIV, gamma/delta T cells, and vaccine development was conducted. Holds a Ph.D. in Immunology and Virology.